Modern Chinese Medicine Group Co (HKSE:01643) Equity-to-Asset : 0.90 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Modern Chinese Medicine Group Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$517.2 Mil. Modern Chinese Medicine Group Co's Total Assets for the quarter that ended in Dec. 2023 was HK$578.1 Mil. Therefore, Modern Chinese Medicine Group Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.90.

The historical rank and industry rank for Modern Chinese Medicine Group Co's Equity-to-Asset or its related term are showing as below:

HKSE:01643' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.56 Med: 0.72 Max: 0.9
Current: 0.9

During the past 7 years, the highest Equity to Asset Ratio of Modern Chinese Medicine Group Co was 0.90. The lowest was 0.56. And the median was 0.72.

HKSE:01643's Equity-to-Asset is ranked better than
94.01% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs HKSE:01643: 0.90

Modern Chinese Medicine Group Co Equity-to-Asset Historical Data

The historical data trend for Modern Chinese Medicine Group Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modern Chinese Medicine Group Co Equity-to-Asset Chart

Modern Chinese Medicine Group Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

Get a 7-Day Free Trial

0.56

0.64

0.85

0.84

0.90

Modern Chinese Medicine Group Co Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial						0.85	0.88	0.84	0.91	0.90

Competitive Comparison of Modern Chinese Medicine Group Co's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modern Chinese Medicine Group Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's Equity-to-Asset falls into.

Modern Chinese Medicine Group Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Modern Chinese Medicine Group Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	517.236	/	578.097
	=	0.89

Modern Chinese Medicine Group Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	517.236	/	578.097
	=	0.89

Modern Chinese Medicine Group Co (HKSE:01643) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Modern Chinese Medicine Group Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Modern Chinese Medicine Group Co (HKSE:01643) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150

Website

http://www.cdysjdyy.com

Modern Chinese Medicine Group Co Ltd is engaged in the production of proprietary Chinese medicine. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, and Additional Ingredient Huoxiang ZhengQi Pill and Fever-removing and Detoxification Pill. The Group has one operating segment of its business as a whole as the production of PCM. Geographically, the majority is from PRC.

Executives

Sun Xinlei	2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si	2101 Beneficial owner
Xie Wei	2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co (HKSE:01643) Headlines

No Headlines